glp 1 competitors GLP-1 Market Industry Trends and Global Forecasts 2024-2035: Over 150 GLP-1 Drug Candidates in Development for Multiple Indications, Type 2 Diabetes and Obesity Drive GLP-1 Drug Development Boom Use of GLP - 1
Description
Randomised clinical trials are warranted to confirm the role of GLP-1 RAs in HS management.
The review further highlights emergent research on "next-generation" therapies with weight-loss efficacy of up to about 24% in clinical trials, approaching weight-loss magnitudes reported in some surgical interventions
The higher dose oral SMG (25 mg and 50 mg) was superior to the 14 mg dose in reducing body weight
10.1016/j.molmet.2020.101102 59 NeelandI
The Biologics Price Competition and Innovation Act (BPCIA) of 2009 created the legal pathway for biosimilar approval in the U.S., analogous to what Hatch-Waxman did for small-molecule generics [13]
doi: 10.1111/nmo.13738 [DOI] [PubMed] [Google Scholar] 26
